Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

about

Short-term use of glucocorticoids and risk of peptic ulcer bleeding: a nationwide population-based case-crossover study.Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.

P2860

Q41652584-FF36F615-83FD-4AE0-978A-8579E0FF7917 Q48832589-C1B0940A-C384-4876-91CC-7FC0250E1CE1

P2860

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

Item

http://www.wikidata.org/entity/Q55084293

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@en

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@nl

type

Item

label

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@en

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@nl

prefLabel

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@en

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@nl

P1476

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

@en

P2093

Ching-Liang Lu

http://www.w3.org/2001/XMLSchema#string

Full-Young Chang

http://www.w3.org/2001/XMLSchema#string

Han-Chieh Lin

http://www.w3.org/2001/XMLSchema#string

Hsiao-Yi Lin

http://www.w3.org/2001/XMLSchema#string

Jia-Min Wu

http://www.w3.org/2001/XMLSchema#string

Jiing-Chyuan Luo

http://www.w3.org/2001/XMLSchema#string

Kuo-Wei Hsiang

http://www.w3.org/2001/XMLSchema#string

Shou-Dong Lee

http://www.w3.org/2001/XMLSchema#string

Tseng-Shing Chen

http://www.w3.org/2001/XMLSchema#string

Yee-Yung Ng

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrotic syndrome in adults

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production.

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Prevalence of Helicobacter pylori infection in long-term hemodialysis patients.

Nonassociation of adrenocorticosteroid therapy and peptic ulcer.

Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy

Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase--two important gastroprotective enzymes.

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats.

P304

756-761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2010.03752.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230130489

http://www.w3.org/2001/XMLSchema#string

P932

2997316

http://www.w3.org/2001/XMLSchema#string

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

about

P2860

P2860

Corticosteroids therapy and peptic ulcer disease in nephrotic syndrome patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P932